Dry Eye Syndrome Market Size & Share, by Type (Evaporative, Aqueous); Diagnosis (Schirmer Test, Eye Exam); Treatment (Nutritional Supplements, Surgery); End-user (Hospitals, Eye Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4587
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Companies Dominating the Dry Eye Syndrome Landscape

    • Lumenis Be Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Johnson & Johnson Services Inc.
    • Alcon Vision LLC
    • Allergan (AbbVie)
    • Novartis AG
    • Allostera Pharma Inc.
    • I-Med Pharma Inc.
    • Acadia Pharmaceutical Inc.
    • Otsuka Pharmaceutical Co. Ltd.
    • Sun Pharmaceutical Industries Ltd. 

Browse Key Market Insights with Data Illustration:


In The News

  •  Alcon launched its latest innovation, Systane iLux2 MGD Thermal Pulsation system, it enhances the dry eye care. This new imaging technology capture HD videos and infrared photos and enables patients to have better understanding about their problem.

  • Novartis AG announced the acquisition of Xiidra, the first ever prescription approved to treat the early signs and symptoms of dry eye problems by preventing inflammation caused by the disease.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4587
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Surging count of people using contact lenses, and rising prevalence of dry eye syndrome are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023-2035.

Several nations lack effective health insurance programmes, and higher cost of the treatment is estimated to challenge the market growth.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Johnson & Johnson Services Inc., Alcon Vision LLC, Allergan (AbbVie), Novartis AG, Allostera Pharma Inc., I-Med Pharma Inc., Acadia Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Lumenis Be Ltd., and others

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, treatment, end user, diagnosis, and by region.

The eye clinics segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying